Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med ; Am J Infect Control ; Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug users using a "shooting gallery. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks.
Ann Intern Med ; Methicillin-resistant and borderline resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors.
Pediatr Infect Dis J ; Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis ; Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.
JAMA ; The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis ; Increase in community-acquired methicillin-resistant Staphylococcus aureus at a naval medical center.
Infect Control Hosp Epidemiol ; Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study.
Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis ; Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Wash with hot water and regular detergent B use bleach when possible. Dry on the hot setting, and make sure clothes are completely dry. Wash hands after handling dirty laundry and before handling clean laundry, even if you have been wearing gloves.
MRSA can live on surfaces for days, weeks, or even months. Clostridium difficile: Contact precautions should remain in place for at least 48 hours after diarrhea resolves. Methicillin-resistant Staphylococcus aureus: For patients not receiving an antibiotic that's active against MRSA , one to three negative cultures should be obtained before discontinuing contact precautions.
The epidemiology of VRE has not been clarified; however, certain patient populations are at increased risk for VRE infection or colonization. Keep cuts, scrapes, and wounds clean and covered until healed. Avoid sharing personal items such as towels and razors.
Get care early if you think you might have an infection. VRSA can be treated with antibiotics, just not vancomycin. Skin infections should be washed with soap and water twice a day and covered with an antibiotic ointment and dressing, if they are draining. Methicillin was effective in those years for the treatment of staphylococcal infections until resistance emerged.
However, that is not the main reason of its discontinuation. Methicillin is no longer commercially available because of its side effects including interstitial nephritis and kidney failure. A vancomycin resistant staphylococcus aureus VRSA infection is caused by bacteria. Later designated community-acquired S. In addition to its virulence, PVL-positive CA-MRSA pose significant public health risks due to its rapid global spread and outbreaks in households and social groups [ 6 ].
Highly variable mutations in a large number of loci affecting regulatory and coding genes lead to increased vancomycin MIC of S. Resistant-bacteria related diseases are a major global health threat that results in infections in an estimated 2 million people, causing 23, deaths each year in the United States alone [ 11 ]. Resistant S. Therefore, the global burden of a VRSA disease epidemic burden would be catastrophic.
Additionally, the potentially devastating effect of global spread will likely lead to resource-related inequity in its containment creating a vicious cycle; with the globalization of travel and organisms' ability to adapt to changing environments, containment would be quite challenging if not impossible. Therefore, without effective control and new antibacterial agents, annual deaths could exceed 10 million by the year [ 13 ].
According to WHO, S. In , vancomycin was first isolated from a strain of Amycolatopsis orientalis formerly Nocardia orientalis found in a soil sample [ 15 ]. The name vancomycin was derived from "vanquish" because of its ability to vanquish resistant Staphylococcus. Despite its effectiveness for Gram-positive infections, vancomycin use was initially low due to its undesirable therapeutic window in the setting of less toxic and equally or more efficacious options.
Multiple events drove these uses that eventually led to significant expansion and current trends. First, vancomycin became the drug of choice for pseudomembranous enterocolitis due to its effectiveness against Clostridium difficile with the additional benefit of poor systemic absorption [ 20 ]. Secondly, there was an exponential increase in its use to treat resistant pathogens, due to epidemics and eventual global spread of severe resistant Gram-positive infections including MRSA diseases [ 21 , 22 ].
Over time, selective pressure led to complex MIC expressions in S. With continued exposure, these heterogeneous vancomycin-intermediate S. The first vancomycin-resistant S. Table 2 summarizes reporting year, case count, source, predisposing factors, and geographical location.
View Table 2. The resistance mechanism of VRSA is mediated by the VanA operon carried on the mobile genetic element Tn acquired from vancomycin-resistant Enterococcus faecalis.
Co-infections with VRE have occurred in all cases [ 21 , 25 ]. There are only a few selected cases of other clinical S. In , VRSA infection was reported in Europe in a year-old with renal and cardiovascular disease [ 26 ]. The patient also harbored VRE. While many of these may represent differences in laboratory isolation methods, it is nonetheless concerning. The clinical impact at this time is unknown [ 24 , 30 , 31 ]. According to the CDC, VRSA disease epidemiology demonstrates geographic clustering that is probably explained by the higher prevalence of precursor organisms in geographically related areas: eight of ten VRSA documented from to occurred in patients from Michigan, and all four VRSA infections since occurred in patients from Delaware.
There has been no documented VRSA transmission to date. The staphylococcal cell wall is a dynamic structure that is critical in host-pathogen interaction. Table 1 shows the timeline for S. Vancomycin resistance among Staphylococcus aureus isolates in a rural setting. Egypt Germs. Adv Vet Anim Res. Article Google Scholar.
Characterization of SCCmec and spa types of methicillin-resistant Staphylococcus aureus isolates from health-care and community-acquired infections in Kerman, Iran.
J Epidemiol Glob Health. The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran. Wien Med Wochenschr. Staphylococcal resistance against five groups of life saving antibiotics in the year — Pak J Pharm Sci. MRSA—retrospective analysis of an outbreak in the burn centre Aachen. Emergence of vancomycin-intermediate and-resistant Staphylococcus aureus among methicillin-resistant S. Bacteriological profile and drug resistance patterns of blood culture isolates in a tertiary care nephrourology teaching institute.
Biomed Res Int. Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India. Guran HS, Kahya S. Species diversity and pheno- and genotypic antibiotic resistance patterns of Staphylococci isolated from retail ground meats. J Food Sci. Molecular characterization of vancomycin, mupirocin and antiseptic resistant Staphylococcus aureus strains. Mediterr J Hematol Infect Dis.
Antibiotic resistance gene profiles of Staphylococcus aureus isolated from foods of animal origin. Kafkas Univ Vet Fak Derg. Icgen B. Bull Environ Contam Toxicol. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant, vancomycin-resistant, and Panton-Valentine leukocidin positive Staphylococcus aureus in a tertiary care hospital Dhaka, Bangladesh.
Tzu Chi Med. Molecular characterization of methicillin and vancomycin resistant Staphylococcus aureus strains isolated from hospitalized patients. Microb Drug Resist. Prevalence and drug resistance pattern of Staphylococcus aureus clinical isolates in Bastar region. J Clin Anal Med. Kumar M. Multidrug-resistant Staphylococcus aureus , India, — Emerg Infect Dis.
Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol. Coagulase-positive staphylococci isolated from chicken meat: pathogenic potential and vancomycin resistance.
Foodborne Pathog Dis. Antibiotic resistance patterns of Staphylococcus aureus : a multi center study from India. Microb Pathog.
Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pac J Trop Biomed. Study on Vancomycin-resistant staphylococcus aureus and identification of VanA gene in these strains isolated from Tabriz Shuhada Hospital using e-test and PCR methods. Life Sci. Neel R. Multidrug resistance of isolates of methicillin resistant Staphylococcus aureus MRSA in paper currency notes from restaurants and hotels in Lusaka in Zambia.
Int J Pharm Sci. Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria. Afr Health Sci. Biomed Res. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital North-West Algeria. Med Mal Infect. Oman Med J. Vancomycin resistance among clinical isolates of Staphylococcus aureus. Arch Iran Med. Correction: Saeed, A. Incidence of vancomycin-resistant phenotype of the methicillin-resistant Staphylococcus aureus isolated from a tertiary care hospital in Lahore.
Antibiotics , 9, 3. Antibiotics Basel. Int J Antimicrob Agents. Antibiotic susceptibility of Staphylococcus aureus in isolates of the patients with osteomyelitis. World J Med Sci. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: a three year study in Tehran, Iran.
Vancomycin-resistant Staphylococcus aureus in the United States, — Clin Infect Dis. Surveillance and evidence of contamination in hospital environment from meticillin and vancomycin-resistant microbial agents.
J Prev Med Hyg. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance. J Coll Phys Surg Pak. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from Doon Valley hospitals.
Uttarakhand Der Pharmacia Lettre. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
J Chemother. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. Emergence of vancomycin resistant Staphylococcus aureus VRSA from a tertiary care hospital from northern part of India.
BMC Infect Dis. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries. Acta Microbiol Immunol Hung. Identification of tigecycline-and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran. Zadegan H. The prevalence of methicillin and vancomycin resistant Staphylococcus aureus nasal carriage in large teaching hospital personnel. Afr J Microbiol Res.
Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med.
0コメント